로딩 중…
StockDiggingStockDigging

NewAmsterdam Pharma Company N.V.

NAMS· NASDAQ
NLNL
$29.83-1.06%
2026-06-18

Price Chart

NewAmsterdam Pharma Company N.V.+63.90%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$3.49B
Revenue$23M
Net Income$-213M
Total Assets$733M
Net Assets$665M
Value
P/B5.24x
P/S154.54x
FCF Yield-4.08%
Profitability
ROE-31.98%
ROA-29.04%
Op. Margin-953.59%
Revenue Growth2.08%
Financial Health
Debt Ratio10.14%
Total Debt$23000.00
FCF$-142M
Cash$458M
Current Ratio9.76x
Performance
1Y Return63.90%
1M Return-11.54%
From 52W High-29.33%
1Y MDD-31.41%
Trading
Volume1,225,830 shares
Trading Value$37M
Per Share
EPS$-1.78
BPS$5.97